Advanced search
Publication Cover
Hematology Volume 24, 2019 - Issue 1
Submit an article Journal homepage
2,674
Views
9
CrossRef citations to date
0
Altmetric
Articles

GDF11 is increased in patients with aplastic anemia

Xifeng DongDepartment of Hematology, General Hospital, Tianjin Medical University, Tianjin, People’s Republic of ChinaView further author information
,
Yu HanDepartment of Hematology, Huaihe Hospital of Henan University, Kaifeng, People’s Republic of ChinaView further author information
,
Iruni Roshanie AbeysekeraDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People’s Republic of ChinaView further author information
,
Zonghong ShaoDepartment of Hematology, General Hospital, Tianjin Medical University, Tianjin, People’s Republic of ChinaView further author information
&
Huaquan WangDepartment of Hematology, General Hospital, Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 331-336 | Published online: 06 Feb 2019

References

  • Townsley DM, Scheinberg P, Winkler T, et al. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. N Engl J Med. 2017;376(16):1540–1550. doi: 10.1056/NEJMoa1613878
  • Gargiulo L, Zaimoku Y, Scappini B, et al. Glycosylphosphatidylinositol-specific T cells, IFN-γ-producing T cells, and pathogenesis of idiopathic aplastic anemia. Blood. 2017;129:388–392. doi: 10.1182/blood-2016-09-740845
  • Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program. 2013;2013:76–81. doi: 10.1182/asheducation-2013.1.76
  • Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428–1436. doi: 10.1182/blood-2016-08-693481
  • Feng X, Scheinberg P, Wu CO, et al. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica. 2011;96:602–606. doi: 10.3324/haematol.2010.030536
  • Liang R, Ghaffari S. Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease. Br J Haematol. 2016;174:661–673. doi: 10.1111/bjh.14194
  • Rochette L, Zeller M, Cottin Y, et al. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration. Pharmacol Ther. 2015;156:26–33. doi: 10.1016/j.pharmthera.2015.10.006
  • Marsh JC, Ball SE, Cavenagh J, et al. British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70. doi: 10.1111/j.1365-2141.2009.07842.x
  • Di Bona E, Rodeghiero F, Bruno B, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol. 1999;107:330–334. doi: 10.1046/j.1365-2141.1999.01693.x
  • Hattangadi SM, Wong P, Zhang L, et al. From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood. 2011;118:6258–6268. doi: 10.1182/blood-2011-07-356006
  • Grover A, Mancini E, Moore S, et al. Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate. J Exp Med. 2014;211:181–188. doi: 10.1084/jem.20131189
  • Wu H, Liu X, Jaenisch R, et al. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 1995;83:59–67. doi: 10.1016/0092-8674(95)90234-1
  • Sankaran VG, Weiss MJ. Anemia: progress in molecular mechanisms and therapies. Nat Med. 2015;21:221–230. doi: 10.1038/nm.3814
  • Suragani RN, Cadena SM, Cawley SM, et al. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late- stage erythropoiesis. Nat Med. 2014;20:408–414. doi: 10.1038/nm.3512
  • Han Y, Zhang GC, Wang HQ, et al. GDF11 is increased in patients with myelodysplastic syndrome. Int J Clin Exp Pathol. 2016;9:6031–6038.
  • Yamagishi S, Matsui T, Kurokawa Y, et al. Serum levels of growth differentiation factor 11 are Independently associated with low hemoglobin values in hemodialysis patients. Biores Open Access. 2016;5:155–158. doi: 10.1089/biores.2016.0015
  • Dussiot M, Maciel TT, Fricot A, et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia. Nat Med. 2014;20:398–407. doi: 10.1038/nm.3468
  • Iancu-Rubin C, Mosoyan G, Wang J, et al. Stromal cell- mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap. Exp Hematol. 2013;41:155–166. doi: 10.1016/j.exphem.2012.12.002
  • Laviano A. Young blood. N Engl J Med. 2014;371:573–575. doi: 10.1056/NEJMcibr1407158
  • Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science. 2014;344:630–634. doi: 10.1126/science.1251141
  • Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014;344:649–652. doi: 10.1126/science.1251152
  • Poggioli T, Vujic A, Yang P, et al. Circulating growth differentiation factor 11/8 levels decline with age. Circ Res. 2016;118:29–37. doi: 10.1161/CIRCRESAHA.115.307521
  • Egerman MA, Cadena SM, Gilbert JA, et al. GDF11 increases with age and inhibits Skeletal muscle regeneration. Cell Metab. 2015;22:164–174. doi: 10.1016/j.cmet.2015.05.010

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.